{"id":"W2558541011","doi":"10.1182/blood.v114.22.3094.3094","title":"Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed/ Refractory Acute Lymphocytic Leukemia.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Clofarabine; Medicine; Internal medicine; Cytarabine; Refractory (planetary science); Gastroenterology; Oncology; Leukemia; Myeloid leukemia; Acute leukemia; Surgery; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001793032,0.000985311,0.001106543,0.0004831934,0.0003974474,0.0005795907,0.0006408674,0.0006562224,0.00550176],"category_scores_gemma":[0.0005039618,0.0004605273,0.0006692978,0.0004376193,0.0005972568,0.0004189704,0.00028546,0.001486004,0.001066488],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009750057,"about_ca_system_score_gemma":0.001973255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001837657,"about_ca_topic_score_gemma":0.006537837,"domain_scores_codex":[0.9995731,0.0002834389,0.00001827461,0.00003794015,0.00003497125,0.00005244452],"domain_scores_gemma":[0.9995849,0.00004465911,0.00007815264,0.00002683524,0.00002106342,0.0002444247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7144104,0.03819579,0.02468892,0.001606787,0.001638251,0.0009038329,0.0004060722,0.002293444,0.06125574,0.0007918434,0.02078618,0.1330227],"study_design_scores_gemma":[0.657621,0.2818579,0.03928838,0.0001275658,0.0006926581,0.0006896761,0.00009897198,0.001832793,0.004222358,0.0002435773,0.01329078,0.00003434508],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840056,0.003130527,0.0003525383,0.0007131355,0.0001162877,0.004513209,0.002999001,0.0001443947,0.004025307],"genre_scores_gemma":[0.971153,0.003236861,0.003294402,0.001826245,0.0001879491,0.004876752,0.008847483,0.00005771828,0.006519589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00550176,"threshold_uncertainty_score":0.0184052,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04012716055413526,"score_gpt":0.3876191216654535,"score_spread":0.3474919611113183,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}